DAX: DE40 gains 0.8% to new ATH📈Siemens Energy surges 9% on US AI infrastructure investments

• Strong stock market opening in Europe; DAX gains 0.8% and hits new historic highs
• Euphoric gains on Siemens Energy (ENR.DE); shares gain 9% - market hopes for a signal of growth from the backdrop of AI infrastructure in the US
• Adidas gains 6% after reporting strong winter sales results
• Berenberg issues 'hold' rating on BMW and Porsche AG; upgrades BMW to 'buy'
• Trump hints at $350 billion trade deficit with EU, but still no specifics on tariffs

Stock markets on the Old Continent are extending gains that accelerate after yesterday's excellent session on Wall Street. In the German market, Siemens Energy, Adidas and SAP stand out, while Porsche AG and Mercedes are losing.

Source: Bloomberg Finance L.P.

Siemens rises on AI wave

The shares of energy and electrification giant Siemens are, on the one hand, more immune to a blow to the renewables industry from Donald Trump, as the company generates 80% of its revenue from wind power and services around it in Europe, while on the other hand it stands to gain from U.S. energy policy, where the new administration will invest some $500 billion to develop the energy sector.

• The company benefits from the need to build new power grids to meet AI's energy needs. According to CEO Joe Kaser, the company is just beginning to increase its share of the US market and is at a very early stage in the overall investment cycle. He estimated that the next 5-10 years will be great for the company, and growth in the U.S. market awaits it.
• In contrast, shares of Denmark's Orsted, which operates exclusively in the wind farm sector, have been losing mightily recently; the stock retreated another 6% today, after taking billions in write-downs on an offshore wind project in the US. Trump has conveyed that he will stop subsidies and end subsidies for 'wind energy' from the federal budget, freezing many of the country's major projects, in this area.

Siemens Energy (D1 interval)

Siemens shares are gaining nearly 340% over the past 12 months and have broken out of their recent consolidation at the top, testing new historical highs. Yesterday's downgrade of the company by UBS analysts, who indicated that the company was already 'perfectly valued' and had no significant potential for continued growth, was instantly 'backfilled' by buyers in the market.Source: xStation5

DE40 (H1 interval)

Źródło: xStation5

Novo Nordisk also stood out positively in the European market today, with its shares gaining more than 2%. Source: xStation5